107 related articles for article (PubMed ID: 12556682)
21. Relationships between CD4 independence, neutralization sensitivity, and exposure of a CD4-induced epitope in a human immunodeficiency virus type 1 envelope protein.
Edwards TG; Hoffman TL; Baribaud F; Wyss S; LaBranche CC; Romano J; Adkinson J; Sharron M; Hoxie JA; Doms RW
J Virol; 2001 Jun; 75(11):5230-9. PubMed ID: 11333905
[TBL] [Abstract][Full Text] [Related]
22. Regional clustering of shared neutralization determinants on primary isolates of clade C human immunodeficiency virus type 1 from South Africa.
Bures R; Morris L; Williamson C; Ramjee G; Deers M; Fiscus SA; Abdool-Karim S; Montefiori DC
J Virol; 2002 Mar; 76(5):2233-44. PubMed ID: 11836401
[TBL] [Abstract][Full Text] [Related]
23. Neutralization of divergent HIV-1 isolates by conformation-dependent human antibodies to Gp120.
Steimer KS; Scandella CJ; Skiles PV; Haigwood NL
Science; 1991 Oct; 254(5028):105-8. PubMed ID: 1718036
[TBL] [Abstract][Full Text] [Related]
24. Passage of HIV-1 molecular clones into different cell lines confers differential sensitivity to neutralization.
Zhang YJ; Fredriksson R; McKeating JA; Fenyö EM
Virology; 1997 Nov; 238(2):254-64. PubMed ID: 9400598
[TBL] [Abstract][Full Text] [Related]
25. Neutralizing antibody response during human immunodeficiency virus type 1 infection: type and group specificity and viral escape.
Arendrup M; Sönnerborg A; Svennerholm B; Akerblom L; Nielsen C; Clausen H; Olofsson S; Nielsen JO; Hansen JE
J Gen Virol; 1993 May; 74 ( Pt 5)():855-63. PubMed ID: 7684062
[TBL] [Abstract][Full Text] [Related]
26. Induction of a Tier-1-Like Phenotype in Diverse Tier-2 Isolates by Agents That Guide HIV-1 Env to Perturbation-Sensitive, Nonnative States.
Johnson J; Zhai Y; Salimi H; Espy N; Eichelberger N; DeLeon O; O'Malley Y; Courter J; Smith AB; Madani N; Sodroski J; Haim H
J Virol; 2017 Aug; 91(15):. PubMed ID: 28490588
[TBL] [Abstract][Full Text] [Related]
27. Interactions of human antibodies, epitope exposure, antibody binding and neutralization of primary isolate HIV-1 virions.
Cavacini LA; Duval M; Robinson J; Posner MR
AIDS; 2002 Dec; 16(18):2409-17. PubMed ID: 12461414
[TBL] [Abstract][Full Text] [Related]
28. Interactions of polyclonal and monoclonal anti-glycoprotein 120 antibodies with oligomeric glycoprotein 120-glycoprotein 41 complexes of a primary HIV type 1 isolate: relationship to neutralization.
Fouts TR; Trkola A; Fung MS; Moore JP
AIDS Res Hum Retroviruses; 1998 May; 14(7):591-7. PubMed ID: 9591713
[TBL] [Abstract][Full Text] [Related]
29. Polymerase chain reaction-based assay for antibody-mediated neutralization of HIV-1 reveals a population of nonneutralized virus undetected by conventional p24 assay.
Achkar JM; Wang XH; Nyambi P; Gorny MK; Zolla-Pazner S; Bandrés JC
J Acquir Immune Defic Syndr; 2000 Jul; 24(3):203-10. PubMed ID: 10969343
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of monoclonal antibodies to HIV-1 envelope by neutralization and binding assays: an international collaboration.
D'Souza MP; Geyer SJ; Hanson CV; Hendry RM; Milman G
AIDS; 1994 Feb; 8(2):169-81. PubMed ID: 7519019
[TBL] [Abstract][Full Text] [Related]
31. Combination effect on HIV infection in vitro of soluble CD4 and HIV-neutralizing antibodies.
Hansen JE; Sørensen AM; Olofsson S; Osinaga E; Roseto A
Arch Virol; 1994; 134(1-2):179-84. PubMed ID: 8279954
[TBL] [Abstract][Full Text] [Related]
32. Stable exposure of the coreceptor-binding site in a CD4-independent HIV-1 envelope protein.
Hoffman TL; LaBranche CC; Zhang W; Canziani G; Robinson J; Chaiken I; Hoxie JA; Doms RW
Proc Natl Acad Sci U S A; 1999 May; 96(11):6359-64. PubMed ID: 10339592
[TBL] [Abstract][Full Text] [Related]
33. Fine mapping of the interaction of neutralizing and nonneutralizing monoclonal antibodies with the CD4 binding site of human immunodeficiency virus type 1 gp120.
Pantophlet R; Ollmann Saphire E; Poignard P; Parren PW; Wilson IA; Burton DR
J Virol; 2003 Jan; 77(1):642-58. PubMed ID: 12477867
[TBL] [Abstract][Full Text] [Related]
34. Chimeric viruses expressing primary envelope glycoproteins of human immunodeficiency virus type I show increased sensitivity to neutralization by human sera.
McKeating JA; Zhang YJ; Arnold C; Frederiksson R; Fenyö EM; Balfe P
Virology; 1996 Jun; 220(2):450-60. PubMed ID: 8661395
[TBL] [Abstract][Full Text] [Related]
35. Neutralization of primary HIV-1 isolates by anti-envelope monoclonal antibodies.
D'Souza MP; Milman G; Bradac JA; McPhee D; Hanson CV; Hendry RM
AIDS; 1995 Aug; 9(8):867-74. PubMed ID: 7576320
[TBL] [Abstract][Full Text] [Related]
36. Herpesvirus saimiri-immortalized human lymphocytes: novel hosts for analyzing HIV type 1 in vitro neutralization.
Vella C; Zheng NN; Easterbrook P; Daniels RS
AIDS Res Hum Retroviruses; 2002 Sep; 18(13):933-46. PubMed ID: 12230936
[TBL] [Abstract][Full Text] [Related]
37. Another discontinuous epitope on glycoprotein gp120 that is important in human immunodeficiency virus type 1 neutralization is identified by a monoclonal antibody.
Ho DD; Fung MS; Cao YZ; Li XL; Sun C; Chang TW; Sun NC
Proc Natl Acad Sci U S A; 1991 Oct; 88(20):8949-52. PubMed ID: 1717992
[TBL] [Abstract][Full Text] [Related]
38. An immune-selected point mutation in the transmembrane protein of human immunodeficiency virus type 1 (HXB2-Env:Ala 582(-->Thr)) decreases viral neutralization by monoclonal antibodies to the CD4-binding site.
Klasse PJ; McKeating JA; Schutten M; Reitz MS; Robert-Guroff M
Virology; 1993 Sep; 196(1):332-7. PubMed ID: 8356803
[TBL] [Abstract][Full Text] [Related]
39. Characterization and epitope mapping of neutralizing monoclonal antibodies produced by immunization with oligomeric simian immunodeficiency virus envelope protein.
Edinger AL; Ahuja M; Sung T; Baxter KC; Haggarty B; Doms RW; Hoxie JA
J Virol; 2000 Sep; 74(17):7922-35. PubMed ID: 10933700
[TBL] [Abstract][Full Text] [Related]
40. Broadly cross-reactive HIV-1-neutralizing human monoclonal Fab selected for binding to gp120-CD4-CCR5 complexes.
Moulard M; Phogat SK; Shu Y; Labrijn AF; Xiao X; Binley JM; Zhang MY; Sidorov IA; Broder CC; Robinson J; Parren PW; Burton DR; Dimitrov DS
Proc Natl Acad Sci U S A; 2002 May; 99(10):6913-8. PubMed ID: 11997472
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]